ANDA 202784, held by Hetero Labs Ltd Iii. Esomeprazole Magnesium.
As of Nov 16, 2026, ANDA 202784 (Esomeprazole Magnesium), held by Hetero Labs Ltd Iii, was first approved by FDA on Sep 21, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 2015 | Original application | Approved |
| Esomeprazole MagnesiumEQ 20MG BASE · capsule, delayed rel pellets;oral | Esomeprazole Magnesium | Discontinued |
| Esomeprazole MagnesiumEQ 40MG BASE · capsule, delayed rel pellets;oral | Esomeprazole Magnesium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters